However, instead of halting the TCA cycle, gamitrinib inhibits the function of complex II of the respiratory chain by antagonizing mitochondrial heat shock protein 90 (Hsp90) as well as by targeting TNF receptor-associated protein 1 (TRAP1) to induce cell death via disrupting mitochondrial respiration in cancer cells [54]. The gene discussed is TRAP1; the disease is cancer.